(Q36285935)

13 August 2017

1 reference

title

Opinion: anticipating change in drug development: the emerging era of translational medicine and therapeutics (English)

1 reference

13 August 2017

main subject

translational medicine

1 reference

Garret A Fitzgerald

1

1 reference

13 August 2017

publication date

1 October 2005

1 reference

Nature Reviews Drug Discovery

13 August 2017

published in

1 reference

13 August 2017

volume

4

1 reference

13 August 2017

issue

10

1 reference

13 August 2017

page(s)

815-818

1 reference

Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes

13 August 2017

cites work

1 reference

Connecting genes to metabolites by a systems biology approach

21 January 2018

1 reference

siRNAs: applications in functional genomics and potential as therapeutics

21 January 2018

1 reference

Knockouts model the 100 best-selling drugs--will they model the next 100?

21 January 2018

1 reference

Developmental expression of functional cyclooxygenases in zebrafish.

21 January 2018

1 reference

An audience with... Janet Woodcock discusses the role of the FDA in improving pharma productivity

21 January 2018

1 reference

National trends in cyclooxygenase-2 inhibitor use since market release: nonselective diffusion of a selectively cost-effective innovation

21 January 2018

1 reference

Cardiovascular hazard and non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

Selective cyclooxygenase 2 inhibitors and cardiovascular events

21 January 2018

1 reference

On the new clinical fashion in epidemiology

21 January 2018

1 reference

Pharmacogenomics and the drug discovery pipeline: when should it be implemented?

21 January 2018

1 reference

Prospects for productivity

21 January 2018

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRD1849

1 reference

13 August 2017

1 reference